Free Listing
Q » What are the risks associated with formulation excipients be optimized in developing countries?
31 Oct, 2025
|
⋮
A » Optimizing formulation excipients in developing countries poses risks such as inconsistent quality due to limited regulatory oversight, potential contamination from inadequate manufacturing practices, and supply chain disruptions. Additionally, there may be challenges in ensuring bioequivalence and stability, which can affect drug efficacy and safety. Addressing these risks requires enhancing regulatory frameworks, investing in local manufacturing capabilities, and fostering international collaboration for technology transfer and quality assurance.
31 Oct, 2025
|
⋮
Still curious? Ask our experts.
Chat with our AI personalities
I'm here to listen you
Taiga
Keep pushing forward.
Always by your side.
Blake
Play the long game.
Vivi
Focus on what matters.
Rafa
Keep asking, keep learning.
Verified
